Varian Medical Systems has acquired the assets of Denver-based OpTx, a privately held supplier of software for medical oncology practices. Varian, which paid approximately $18 million cash to obtain the assets, plans to continue to develop, sell,
Varian Medical Systems has acquired the assets of Denver-based OpTx, a privately held supplier of software for medical oncology practices. Varian, which paid approximately $18 million cash to obtain the assets, plans to continue to develop, sell, install, and service OpTxTools software worldwide as a stand-alone product for medical oncology practices and as part of its VARiS software for coordination with radiation oncology. With this acquisition, Varian is able to offer an integrated single software system for managing and coordinating radiation therapy and chemotherapy routinely used in the treatment of cancer, according to the company. The acquisition is expected to add annualized revenues of $9 million to Varian coffers and be nearly neutral to earnings for the company in fiscal year 2004.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.